Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

Cavé, Hélène; van der Werff ten Bosch, Jutte; Suciu, Stefan; Guidal, C; Waterkeyn, C; Otten, J.; Bâkkus, Marleen; Thielemans, Kris; Grandchamp, Bernard; Vilmer, E; Nelken, Brigitte; Fournier, Martine; Boutard, Patrick; Lebrun, Emmanuel; Méchinaud, Françoise; Garand, Richard; Robert, Alain; Dastugue, Nicole; Plouvier, Emmanuel; Racadot, E; Ferster, A; Gyselinck, Jan; Fenneteau, Odile; Duval, Michel; Solbu, G.; Manel, Anne‐Marie

doi:10.1056/nejm199808273390904

Public

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

Published in New England Journal of Medicine • Aug 27, 1998

Authors:

Hélène Cavé

Jutte van der Werff ten Bosch

Stefan Suciu

Abstract

BACKGROUND AND METHODS: The implications of the detection of residual disease after treatment of acute lymphoblastic leukemia (ALL) are unclear. We conducted a prospective study at 11 centers to determine the predictive value of the presence or absence of detectable residual disease at several point...

Subject

Medicine

Minimal residual disease

Lymphoblastic Leukemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!